Noticias de Jiangsu Hengrui Pharmaceuticals

Últimas noticias

Titulares en el idioma original de la fuente.

• 
  1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges (se abre en una pestaña nueva)

  StockStory · 6 oct 2026

• 
  Tilray Brands: Is the Stock a Buy at Less Than $4? (se abre en una pestaña nueva)

  Motley Fool · 6 oct 2026

• 
  Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026? (se abre en una pestaña nueva)

  Motley Fool · 6 oct 2026

• 
  Option Care Health Soars 33% on $5.8 Billion Buyout by CD&R and McKesson: “A Great Outcome” (se abre en una pestaña nueva)

  TIKR · 6 oct 2026

• 
  Outlook Therapeutics Highlights What the Appointment of New CFO Kevin Lundquist Means for the Company’s Next Chapter in Virtual Investor Discussion (se abre en una pestaña nueva)

  GlobeNewswire · 6 oct 2026

• Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million (se abre en una pestaña nueva)

  TMX Newsfile · 6 oct 2026

• 
  bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026 (se abre en una pestaña nueva)

  Business Wire · 6 oct 2026

• 
  Foundayo Showed Better Results Than Oral Semaglutide in a New Analysis. There’s a Catch Investors Shouldn’t Miss (se abre en una pestaña nueva)

  Insider Monkey · 6 oct 2026

• 
  Simulations Plus Announces Completion of Acquisition by Altaris (se abre en una pestaña nueva)

  Business Wire · 6 oct 2026

• 
  Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026 (se abre en una pestaña nueva)

  GlobeNewswire · 6 oct 2026

• ArriVent stock tumbles 60% after trial misses primary endpoint (se abre en una pestaña nueva)

  Investing.com · 6 oct 2026

• Fortitude Doubles Down on Zcash Mining With $100M BITMAIN Commitment (se abre en una pestaña nueva)

  6 oct 2026

• The $110 Billion Paramount-Warner Merger Closes Today. What Shareholders Need to Know (se abre en una pestaña nueva)

  6 oct 2026

• GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications (se abre en una pestaña nueva)

  6 oct 2026

• Vizient Expands Supply Assurance for IV Solutions Through Collaboration With Fresenius Kabi (se abre en una pestaña nueva)

  6 oct 2026

• Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement (se abre en una pestaña nueva)

  6 oct 2026

• Repligen Completes Acquisition of BioLife Solutions (se abre en una pestaña nueva)

  6 oct 2026

• PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (se abre en una pestaña nueva)

  6 oct 2026

• 
  2 Cash-Producing Stocks to Research Further and 1 We Find Risky (se abre en una pestaña nueva)

  StockStory · 6 oct 2026

• Tesla And 2 More High Growth Insider Stocks To Watch (se abre en una pestaña nueva)

  6 oct 2026